Key result
This review outlines the risks and benefits of pharmacological options and extracorporeal techniques like ultrafiltration for managing fluid overload in heart failure.
Why the study?
Fluid overload increases morbidity and mortality in heart disease, while treatment options are limited to diuretics and mechanical fluid removal.
This review provides an overview of the challenges, risks, and benefits of managing fluid overload in heart disease using pharmacological options and extracorporeal techniques.
Management of fluid overload in heart disease remains limited to diuretics and mechanical removal; leaves open need for novel targeted therapies.
Fluid overload is a risk factor for increased morbidity and mortality, especially in patients with heart disease. The treatment options are limited to diuretics and mechanical fluid removal using ultrafiltration or renal replacement therapy. This paper provides an overview of the challenges of managing fluid overload, outlines the risks and benefits of different pharmacological options and extracorporeal techniques, and provides guidance for clinical practice.
No takes yet. Share an insight, caveat, or question.
Reis et al. (2023) conducted a review in Heart Failure. Diuretics and Ultrafiltration was evaluated. This review outlines the risks and benefits of pharmacological options and extracorporeal techniques like ultrafiltration for managing fluid overload in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: